Find Academic Supervisors

Find and connect with academic supervisors, professors, and scholars for your research journey.

Showing 736-750 of 11,582 supervisors

Profile data may be stale. It is sourced from public faculty pages.

Frank LongoView profile

Professor

Stanford UniversityUnited States

Frank Longo is a Professor in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine. He actively teaches across the neuroscience curriculum including Medical Scholars Research (NENS 370), Directed Reading courses (NEPR 299/NENS 299), Graduate Research (NENS 399/NEPR 399), and Early Clinical Experience (NENS 280), demonstrating his commitment to training the next generation of neuroscientists and clinicians. His research program centers on neurodegenerative diseases with particular emphasis on Alzheimer's, Huntington's, and Parkinson's diseases. Longo investigates the therapeutic potential of neurotrophin receptor modulation (especially p75NTR and TrkB) using small-molecule ligands like LM11A-31, exploring mechanisms spanning protein aggregation, synaptic dysfunction, neuroinflammation, and metabolic dysregulation. His work bridges molecular neuroscience with translational applications, utilizing advanced techniques including transcriptomics, neuroimaging, and biomarker analysis in cellular and animal models. Analysis of his 2024-2025 publications reveals consistent focus on targeting neurotrophin pathways to reverse disease phenotypes. Key themes include: 1) Development of small-molecule modulators for p75NTR/TrkB to rescue synaptic and cognitive deficits; 2) Biomarker discovery for early detection (e.g., plasma Aβ42/Aβ40 ratios); 3) Mechanistic studies on autophagy, white matter changes, and metabolic dysfunction; and 4) Leadership in collaborative initiatives like the TREAT-AD Center for target validation. His research demonstrates both breadth across neurodegenerative disorders and depth in neurotrophin signaling mechanisms. Through undergraduate and graduate research courses, Longo mentors students in neuroscience research despite no specific advisees being listed. His extensive publication record and involvement in multi-institutional consortia (including EU-US task forces) indicate significant research funding and national leadership in neurodegenerative disease research, though specific grant details aren't provided in the source material.

Official University Profile

Dietmar SchlosserView profile

Researcher

Helmholtz Centre for Environmental ResearchGermany

Dr. Dietmar Schlosser is a Group Leader in Environmental Mycology at the Department of Applied Microbial Ecology within the Helmholtz Center for Environmental Research - UFZ since 2005. His research program focuses on fungal biodegradation of environmental pollutants, particularly synthetic polymers, micro-pollutants, and recalcitrant organic compounds. Education : Diploma in Biology (1990), Friedrich Schiller University Jena PhD in Technical Microbiology (1993), Friedrich Schiller University Jena His research integrates ecological principles with applied biotechnology , emphasizing fungal biochemistry, physiology, and enzymology. Key projects include: TapNature (2021-2027): Exploiting natural fungal systems for bioeconomy FINEST Microplastics (2022-2027): Sustainable materials management PUreValue (2024-2027): Polyurethane biodegradation for upcycling CLEANER (2023-2026): Water cycle resilience in cities Article trends reveal expertise in mycoremediation , lignocellulose valorization , and fungal attack on synthetic polymers , with recent work spanning environmental engineering, microbiology, and biochemical monitoring techniques. He maintains active collaborations with institutions across Europe and contributes to sustainable technology development through his leadership in Environmental Mycology .

Official University Profile

Patricia C. LopesView profile

Associate Professor

Chapman UniversityUnited States

Dr. Patricia C. Lopes is an Associate Professor at Schmid College of Science and Technology, Chapman University. Her research focuses on animal social behavior, disease transmission, and neuroendocrinology, integrating molecular, physiological, and social dynamics. She employs RFID tracking and behavioral sensors in field and lab experiments to study sickness behaviors and their evolutionary implications. Education: Ph.D. from University of California, Berkeley. Labs: Runs the Lopes Lab, investigating social decision-making networks and infection responses in wild house mice ( Mus musculus domesticus ). Research Highlights: Challenges the kin protection hypothesis for sickness behaviors through experiments on wild and lab mice. Demonstrates that social isolation alters neural transcriptomes and affects disease spread dynamics. Explores maternal physiological responses to infection risks and integrates ecoimmunology with disease ecology frameworks. Key Collaborations: Works with institutions like ETH Zurich, University of Bern, and University of Zurich. Collaborates with experts in behavioral ecology (Barbara König), neurogenomics (Suzy C. P. Renn), and disease dynamics (Greg Albery).

Official University Profile

Darshana M. DadhaniaView profile

Associate Professor

Weill Cornell MedicineUnited States

Darshana M. Dadhania, M.D., M.S., D(ABHI), is an Associate Professor of Medicine at Weill Cornell Medical College and an Associate Attending Physician at NewYork-Presbyterian Hospital. She serves as Medical Director of the Kidney and Pancreas Transplant Program and Program Director of the Transplant Nephrology Fellowship. Additionally, she is Director of the Genomics Division and Associate Director of the Immunogenetics and Transplantation Center. Education: M.D. from University of Medicine and Dentistry of NJ; M.S. in Clinical and Translational Investigation from Weill Cornell; B.A., B.S. from Stevens Institute of Technology. Training: Internal Medicine Residency, Nephrology Fellowship, and Transplant Medicine Fellowship at NewYork-Presbyterian Hospital; additional training in histocompatibility testing. Certifications: Board Certified in Internal Medicine and Nephrology; Diplomate, American Board of Histocompatibility and Immunogenetics. Dr. Dadhania's research focuses on noninvasive biomarkers for kidney allograft outcomes, particularly urinary cell mRNA and cell-free DNA profiling for rejection detection, management of highly sensitized patients, and infectious complications post-transplant. She has pioneered work in gut microbiota interactions with immunosuppression and infection risk. Her studies integrate genomics, immunology, and clinical outcomes to improve long-term transplant success. Her recent publications (2023–2025) emphasize noninvasive diagnostics using urinary biomarkers, consensus development in antibody-mediated rejection (Banff Working Group), kidney paired donation trends, and integration of palliative care in transplant failure. These works span high-impact journals including Nature Medicine , American Journal of Transplantation , and Transplantation , reflecting a strong translational and clinical research trajectory. Elected Fellow, American Society of Transplantation (2015) President, New York Society of Nephrology (2014–2015) Chair, Kidney Pancreas Community of Practice, American Society of Transplantation (2017–2019) Co-Chair, Consensus Conferences on Frailty, Cardiovascular Disease, and Heart-Kidney Transplantation Editorial Board, Nephrology, Dialysis and Transplantation and Transplantation Recipient of multiple investigator awards and leadership recognitions since 2003 Dr. Dadhania has served as site Principal Investigator for NIH-supported CTOT-03 and CTOT-04 trials and currently leads multiple studies including the APOLLO Consortium and metagenomic profiling of urinary cell-free DNA. She mentors fellows through her fellowship directorship and contributes to national policy via consensus guidelines and editorial leadership. Her work bridges clinical care, research innovation, and education in transplant nephrology. She leads the Genomics Division and Immunogenetics and Transplantation Center, where her team develops and validates molecular assays for allograft monitoring. Her lab collaborates extensively with biopharma partners and national consortia to translate biomarkers into clinical practice.

Official University Profile

Soner DoğanView profile

Professor

Yeditepe UniversityTurkey

Prof. Soner Doğan is a Professor at Yeditepe University's Faculty of Medicine, Department of Medical Biology. He holds a PhD in Medical Biology from the University of Minnesota and a Bachelor's in Veterinary Science from Ankara University. His research bridges oncology, epigenetics, and metabolic regulation, with a focus on breast cancer mechanisms and calorie restriction. Research interests span: Breast Cancer Pathobiology : Investigating leptin/adiponectin signaling and epigenetic modifications in tumor development. Calorie Restriction : Examining intermittent vs. chronic dietary interventions for cancer prevention and aging. Aging and Frailty : Identifying biomarkers and molecular pathways in age-related diseases using murine models. His publications emphasize molecular oncology, with recurring themes in adipokine signaling, DNA methylation, and transcriptomic profiling. Articles frequently utilize transgenic mouse models and RNA-seq to explore metabolic and immune interactions in cancer. Awards & Honors: Professional Development Grant, Education Minnesota Foundation AICR Scholarship for Cancer Research Conference Advising & Grants : Supervised 11+ Master's/PhD theses on topics like nanoparticle drug delivery and epigenetic regulation. Secured major grants including TÜBİTAK 1001 (€395K) for breast cancer epigenetics and COST Action CA17129 for cardiovascular transcriptomics. Affiliations : Leads projects at Yeditepe’s molecular biology labs and collaborates internationally (e.g., EU-CardioRNA COST Action). Holds administrative roles as Department Coordinator and Ethics Committee member.

Official University Profile

Christopher HoweView profile

Professor

University of CambridgeUnited Kingdom

Professor Christopher Howe is a Professor of Plant and Microbial Biochemistry at the Department of Biochemistry, University of Cambridge . He has been a Fellow of the College since 1983 and currently serves as its President . He directs studies in Preclinical Medicine , teaching Biochemistry to first-year medical students. Research Interests : Photosynthesis biochemistry and evolution Biotechnological applications of photosynthetic organisms (e.g., algae for electricity production) Plasmodium's photosynthetic ancestry and remnant chloroplast Evolutionary analysis of non-biological systems like manuscripts Coral bleaching and dinoflagellate-coral symbiosis Article Trends : Focus on cyanobacteria, dinoflagellates, and Plasmodium Biophotovoltaic systems and sustainable energy Phylogenetic methods in biological and cultural evolution Scientific Awards : Fellow of the American Academy of Microbiology (2017) Advising and Collaborations : Supervises graduate students in the Howe Group Collaborates with academic and commercial partners (Anaero Technology, LEITAT, Spireat) Labs & Teams : Leads the Howe Group at the Department of Biochemistry Co-leads the BEST Project for biophotovoltaic systems Works with 3D organotypic cultures and biophotoelectrochemistry

Official University Profile

Robert NordonView profile

Associate Professor

University of New South WalesAustralia

Associate Professor Robert Nordon is a faculty member at UNSW Sydney's Graduate School of Biomedical Engineering. He holds an MB BS, BMedSci, and PhD, with research focusing on advanced manufacturing and medical technologies. Since 2016, he has secured over $5M in research grants for projects in point-of-care diagnostics, cell/gene therapy manufacturing, and stem cell science. Research interests span three primary domains: Developing microfluidic single-use disposables for scalable clinical cell production Modeling cardiovascular development using stem cell-based microfluidic systems Creating computational tools for single-cell analysis and lineage tracking His publications (2017-2024) demonstrate strong emphasis on microfluidic device engineering, stem cell dynamics, and biomaterials development. Recurring themes include hematopoietic stem cell expansion, cardiac cell behavior, and peptide-based biomaterials. Significant grants include: ARC Linkage Grant LP160100570: Scaling microfluidics for cell manufacture (2016-2019) ARC Linkage Grant LP160100573: 3D microstructures for medical devices (2016-2019) ARC Linkage Grant LP190100029: Electrophoretic cell sorters (2020-2023) CRC-P: Microbioreactor for affordable cell/gene therapy (2021-2023) Current research trainees include Farzaneh Ziaee and Eric Du.

Official University Profile

Marcel DingerView profile

Professor

University of New South WalesAustralia

Professor Marcel Dinger is a prominent academic and researcher currently serving as Professor and Head of School for Biotechnology and Biomolecular Sciences at UNSW Sydney. With over 20 years of experience in genomics, he has established himself as a leading figure in both academic and entrepreneurial spheres within the field. He has published 153 papers with over 24,000 citations and maintains an h-index of 61 on Google Scholar. His leadership extends beyond academia as he serves as President of the Australasian Genomics Technologies Association (AGTA) and holds director positions at Pryzm Health and the National Centre for Indigenous Genomics (NCIG). Professor Dinger's research laboratory focuses on establishing new links between phenotype and genotype, particularly examining rare and complex diseases in relation to underexplored regions of the genome including pseudogenes, repetitive elements, non-canonical DNA structures, and noncoding RNAs. His work harnesses population-scale genomic datasets and sophisticated data science methods to bring an objective perspective to understanding how the genome stores information and how it is transacted in biology. His research interests span genomics, non-coding RNA biology, clinical applications of genomic medicine, and the development of computational approaches for analyzing complex genomic data. Analysis of Professor Dinger's recent publications reveals a strong emphasis on non-coding RNA research, particularly long noncoding RNAs and their roles in disease mechanisms. His work spans cancer genomics, neurological disorders, and fundamental genomic mechanisms including DNA secondary structures like i-motifs and G-quadruplexes. His research combines experimental approaches with advanced bioinformatics to address fundamental questions in genomic medicine and has significant translational implications for disease diagnosis and treatment. Highly Cited Researcher in Cross-Field category (2019, 2020, 2021) Fellow of the Faculty of Science (Research), Royal Society of Pathologists of Australasia (2016) NHMRC Career Development Award (2010) Queensland Government Smart Futures Fellowship (2009) Foundation of Research, Science and Technology New Zealand Postdoctoral Fellowship (2005) Professor Dinger has been instrumental in establishing and leading several significant research initiatives including Genome.One, one of the first companies globally to provide clinical whole genome sequencing services, and the Kinghorn Centre for Clinical Genomics at the Garvan Institute of Medical Research. His entrepreneurial experience includes founding four biotechnology and IT startups. He serves on multiple governance boards including the National Centre for Indigenous Genomics, focusing on using genomics to improve health outcomes for Australia's First Peoples. His laboratory at UNSW continues to advance our understanding of genomic regulation and its implications for human health and disease.

Official University Profile

Kang ChenView profile

Professor

Wayne State UniversityUnited States

Professor Kang Chen is a faculty member at the Wayne State University School of Medicine with joint appointments in the Department of Obstetrics and Gynecology , Biochemistry, Microbiology and Immunology , Oncology , and the Center for Molecular Medicine and Genetics . He co-chairs the Immunology Focus Group across Wayne State University, Karmanos Cancer Institute, and Henry Ford Health. PhD : Weill Cornell Medicine, Memorial Sloan-Kettering Cancer Center, Hospital for Special Surgery BSc (First-Class Honours): National University of Singapore Dr. Chen's research focuses on immune regulation of cancer , reproductive disorders , and mucosal immunity . His lab investigates antibody diversification mechanisms in B cells, immunoglobulin class switching and somatic hypermutation dysregulation in diseases, and maternal-fetal immune interactions affecting pregnancy outcomes. Recent publications highlight his work on WWC proteins in tumor suppression (2025), gene therapy for mesothelioma (2024), IgD-basophil interactions (2023), Maspin in cancer stem cell regulation (2022), and preterm labor immunoprotection (2017). His studies span immunology , oncology , and reproductive medicine . Scientific Awards American Association of Immunologists Travel Awards (2023, 2025) College Teaching Awards (2020, 2017) Research Excellence Award (2016) Burroughs Wellcome Fund Investigator (2014) NIH MIST Young Investigator Award (2013) Dr. Chen teaches Immunology , Cancer Immunotherapy , and Reproductive Biology courses at Wayne State University. His lab collaborates with academic and clinical partners across institutions, leveraging molecular, cellular, and animal model approaches to develop novel therapeutics for cancer and immune-related reproductive disorders. As principal investigator, he leads studies on maternal-fetal immune crosstalk , antibody diversification , and mucosal immunology , with patents in therapeutic antibody generation and preterm labor prevention .

Official University Profile

Dilber Ece UzunView profile

Associate Professor

Brown UniversityUnited States

Dilber Ece Uzun is an Associate Professor of Pathology and Laboratory Medicine at Brown University and a founding Director of Clinical Bioinformatics at Lifespan Academic Medical Center. She also serves as Associate Director of the Center for Clinical Cancer Informatics and Data Science (CCIDS) and Editor-in-Chief of JMIR Bioinformatics and Biotechnology . B.S., Chemical Engineering, Istanbul Technical University M.S., Biological Sciences and Bioengineering, Sabanci University PhD, Chemical Engineering, Northeastern University (Boston, MA) Her research focuses on translational bioinformatics and machine learning-based predictive models applied to cancer and neurodevelopmental disorders , particularly autism spectrum disorder and precision medicine . She has developed computational genetics frameworks and drug delivery models. Her publications span genetics , bioinformatics , drug delivery systems , and neurodevelopmental disorder analysis, with a strong emphasis on machine learning and predictive modeling in both cancer and autism research. 2022 : Brown University Karen T. Romer Prize for Undergraduate Advising and Mentoring 2013 : First Place, DPHB Research Day Poster Competition 2012 : First Place, DPHB Research Day Poster Competition 2010 : Fellowship from Brown University Institute for Brain Science 2009 : Fellowship from Northeastern University Provost Office 2007 : Multiple teaching and poster competition awards Dr. Uzun leads the Translational Bioinformatics Lab and collaborates with Brown University's Center for Computational Molecular Biology and Center for Translational Neuroscience .

Official University Profile

Taofic MounajjedView profile

Consultant Lecturer

Mayo Clinic College of Medicine and ScienceUnited States

Taofic Mounajjed, M.D. is a Consultant Pathologist specializing in liver and gastrointestinal pathology at the Mayo Clinic in Rochester, Minnesota. He serves as Co-Director of the Molecular Anatomic Pathology Laboratory and Co-Section Head within the Department of Laboratory Medicine and Pathology. Dr. Mounajjed is actively involved in multiple professional committees focused on digital pathology and pathology informatics. MD from University of Damascus Medical School (2004) BS in Basic Medical Sciences from University of Damascus (1999) Residency in Anatomic and Clinical Pathology at University of Cincinnati (2009) Residency in Surgical & Medical Pathology at Mayo Clinic (2010) Fellowship in Surgical Pathology at Mayo Clinic (2010) Mayo Clinic Scholar in Gastrointestinal and Hepatic Pathology (2011) Dr. Mounajjed's research focuses on liver pathology with particular expertise in hepatic adenomas, focal nodular hyperplasia, and gastrointestinal pathology. His work spans diagnostic pathology, molecular characterization of liver diseases, and implementation of digital pathology technologies. He has made significant contributions to understanding the histopathological features of various liver conditions including Wilson disease, eosinophilic esophagitis, and alcohol-related liver disease. His recent publications demonstrate a strong focus on advanced imaging techniques for liver disease assessment, particularly magnetic resonance elastography for evaluating liver fibrosis and steatosis. There is also a notable emphasis on AI applications in pathology, particularly for quantitative histopathological analysis of gastrointestinal conditions. His work bridges traditional pathology with modern computational approaches and molecular diagnostics. Best graduation thesis for the year 1999 from University of Damascus Certified by American Board of Pathology in Anatomic Pathology (2010) Certified by American Board of Pathology in Clinical Informatics (2019) Dr. Mounajjed serves in leadership roles including Chair of the DLMP Digital Pathology Practice Subcommittee and member of multiple digital pathology committees. He co-directs the Molecular Anatomic Pathology Laboratory and participates in various disease-oriented groups focusing on gastrointestinal and hepatic conditions. His collaborative research involves extensive work with multidisciplinary teams across Mayo Clinic, including radiology, gastroenterology, and surgery departments.

Official University Profile

Karlijn A. C. MeeksView profile

Assistant Professor

University of Maryland, BaltimoreUnited States

Dr. Karlijn A. C. Meeks serves as Assistant Professor in the Department of Medicine at the University of Maryland School of Medicine with secondary appointment in Epidemiology & Public Health, conducting research through the Division of Endocrinology, Diabetes, and Nutrition focused on cardiometabolic diseases in African-ancestry populations across sub-Saharan Africa and the diaspora. Her academic credentials include: B.Sc. in Nutrition and Health, Wageningen University (2010) M.Sc. in Nutrition and Health, Wageningen University (2012) Ph.D. in Public Health Epidemiology, University of Amsterdam (2017) Postdoctoral training in Epidemiology, Amsterdam University Medical Centers (2018) Postdoctoral training in Genetic Epidemiology, National Institutes of Health (2024) Dr. Meeks pioneers research in genetic and epigenetic epidemiology of obesity, type 2 diabetes, and dyslipidemia through innovative multi-omics approaches that integrate genomics, epigenomics, transcriptomics, and metabolomics with classical epidemiological methods. Her work specifically targets historically underrepresented African populations using comparative migrant studies across geographical settings to dissect environmental versus genetic contributions to disease. She has published over 80 peer-reviewed articles with recent work (2019-2023) establishing foundational knowledge in African-ancestry populations through first-of-kind epigenome-wide association studies and genome-wide analyses of cytokines. Her publications in Genome Medicine , EBioMedicine , and International Journal of Epidemiology demonstrate consistent focus on Mendelian randomization, biomarker discovery, and improving risk prediction models for cardiometabolic diseases in underrepresented groups. Her major scientific recognition includes: NIH Pathway to Independence Award (K99/R00) As principal investigator of the NIH K99/R00 award, Dr. Meeks leads research examining interactions between lifestyle factors, cytokines, genetic variants, and epigenetic biomarkers in type 2 diabetes pathogenesis among African-ancestry populations. While specific advisees aren't documented in source materials, her work involves extensive international collaboration through consortia like the RODAM study. Dr. Meeks operates within the University of Maryland's Division of Endocrinology, Diabetes, and Nutrition while maintaining active research partnerships with institutions across sub-Saharan Africa and the National Institutes of Health, driving global health equity through population-specific genomic and epigenetic research frameworks.

Official University Profile

Zach Gerhart-HinesView profile

Associate Professor

University of CopenhagenDenmark

Zach Gerhart-Hines is an Associate Professor at the Faculty of Health and Medical Sciences , University of Copenhagen. He leads the Gerhart-Hines Group and focuses on adipose tissue biology and energy metabolism. Education : PhD in Biochemistry-Cellular and Molecular Biology from Johns Hopkins University (2011) Research Interests : His work explores how environmental signals, diet, circadian rhythms, and organ communication regulate adipose tissue plasticity. Using multi-omics and in vivo phenotyping, his group identifies key regulatory nodes in adipocytes to combat metabolic diseases. Publications : His recent studies span topics from lactate research artifacts to novel chemokine signaling in brown adipose tissue. Key themes include succinate transport, NAD metabolism, and cold stress adaptations in obesity models. Collaborations : Collaborates with researchers in diabetes, cancer metabolism, and exercise physiology including Claus Clemmensen, Thomas W. Schwartz, Juleen Zierath, and Lykke Sylow. Conflict of Interest : Co-founder of Embark Biotech ApS, a company targeting type 2 diabetes and obesity therapeutics.

Official University Profile

Frank MelznerView profile

Professor

Helmholtz Centre for Ocean Research KielGermany

Professor Frank Melzner is a leading marine ecologist and group leader of the Ecophysiology Working Group at GEOMAR Helmholtz Centre for Ocean Research Kiel. His research focuses on understanding how marine invertebrates respond physiologically to changing environmental conditions, particularly ocean acidification, warming, and deoxygenation. He is affiliated with the Department of Marine Ecology, specifically within Department 3, Research Unit 'Experimental Ecology - Benthic Ecology' at GEOMAR. His research interests span multiple dimensions of marine physiological ecology: Marine invertebrate zoology & environmental physiology Acid-base regulation in marine organisms Biomineralization processes in calcifying organisms Physiological adaptations to changing ocean conditions Interactions between abiotic stressors and marine food webs Winter warming impacts on marine ecosystems Professor Melzner's extensive publication record demonstrates a strong focus on understanding how marine organisms, particularly bivalves and echinoderms, respond to multiple stressors in a changing ocean. His work combines laboratory experiments with field observations to assess both short-term physiological responses and potential for long-term adaptation. A significant portion of his research examines how ocean acidification affects calcification processes, with particular attention to the underlying cellular mechanisms. His recent work has increasingly focused on the interactive effects of multiple stressors, including temperature, CO 2 , and salinity, with a special emphasis on Baltic Sea ecosystems where these factors interact in unique ways. Professor Melzner leads a productive research group that includes postdocs, PhD students, and technical staff. His laboratory at GEOMAR's Kiel facility conducts innovative experiments using the Kiel Outdoor Benthocosms (KOBs) and other advanced experimental systems to simulate future ocean conditions. This outdoor mesocosm facility has enabled groundbreaking research on winter warming effects that would be difficult to conduct in traditional laboratory settings. His mentoring record shows strong commitment to student development, with numerous successful M.Sc. and Ph.D. students who have gone on to pursue academic and research careers at institutions worldwide. His collaborative approach is evident in his extensive co-authorship network spanning multiple countries and disciplines.

Official University Profile

Carlos Guerrero BosagnaView profile

Senior Lecturer

Uppsala UniversitySweden

Carlos Guerrero Bosagna is a Senior Lecturer at Uppsala University's Department of Organismal Biology; Physiology and Environmental Toxicology. His research bridges evolutionary biology, epigenetics, and environmental science, focusing on how environmental exposures (e.g., toxins, stress) induce epigenetic modifications that influence developmental processes and transgenerational phenotypic variation. Role: Senior Lecturer, Uppsala University Department: Physiology and Environmental Toxicology Key Projects: Epigenetic stress response in chickens, metabolic/reproductive effects of environmental toxins, germline epigenetic variation in speciation His work has secured a FORMAS grant for modeling environmental toxicant impacts on chicken reproduction and metabolism. Recent publications analyze avian methylation patterns , mito-nuclear interactions , and Z-chromosome epigenetic regulation . Collaborations span poultry science, computational biology, and global environmental epigenetics research. Scientific awards include a FORMAS grant for environmental toxicology research His research emphasizes sustainability and evolutionary innovation, with lab projects tracking epigenetic changes across six generations to mimic early speciation events. Methodological contributions include protocols like GBS-MeDIP for concurrent genetic/epigenetic analysis.

Official University Profile

Showing search results up to the first 750 matches. Narrow your search with filters to find more specific results.